Fig. 2From: Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: a phase 2, randomised, observer-blind studyStudy design. CMI, cell-mediated immunity; D, study day; M, study month; N, number of participants; Mcat, Moraxella catarrhalis; NTHi, non-typeable Haemophilus influenzaeBack to article page